[{"address1": "4546 El Camino Real", "address2": "Suite B1", "city": "Los Altos", "state": "CA", "zip": "94022", "country": "United States", "phone": "650 284 4433", "fax": "650 397 4433", "website": "https://renovorx.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ramtin  Agah M.D.", "age": 57, "title": "Founder, Chairman of Board & Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 332894, "exercisedValue": 0, "unexercisedValue": 173000}, {"maxAge": 1, "name": "Mr. Shaun R. Bagai", "age": 46, "title": "CEO, Secretary & Director", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 589376, "exercisedValue": 0, "unexercisedValue": 304200}, {"maxAge": 1, "name": "Mr. Ronald B. Kocak CPA, CGMA", "age": 66, "title": "VP, Controller & Principal Accounting Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leesa  Gentry", "age": 53, "title": "Chief Clinical Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Witt", "title": "Senior VP and Head of Corporate Strategy & Partnerships", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.0, "open": 1.0, "dayLow": 0.98, "dayHigh": 1.03, "regularMarketPreviousClose": 1.0, "regularMarketOpen": 1.0, "regularMarketDayLow": 0.98, "regularMarketDayHigh": 1.03, "beta": 0.984, "forwardPE": -2.4390244, "volume": 9484, "regularMarketVolume": 9484, "averageVolume": 31431, "averageVolume10days": 15290, "averageDailyVolume10Day": 15290, "marketCap": 23986700, "fiftyTwoWeekLow": 0.531, "fiftyTwoWeekHigh": 2.35, "fiftyDayAverage": 1.04106, "twoHundredDayAverage": 1.236885, "currency": "USD", "enterpriseValue": 12244709, "floatShares": 23530002, "sharesOutstanding": 23986700, "sharesShort": 114311, "sharesShortPriorMonth": 54404, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.0047999998, "heldPercentInsiders": 0.01904, "heldPercentInstitutions": 0.03728, "shortRatio": 2.3, "shortPercentOfFloat": 0.0049, "bookValue": 0.387, "priceToBook": 2.5839794, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -8113000, "trailingEps": -0.6, "forwardEps": -0.41, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "RNXT", "underlyingSymbol": "RNXT", "shortName": "RenovoRx, Inc.", "longName": "RenovoRx, Inc.", "firstTradeDateEpochUtc": 1629984600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "6babfc24-dc5c-3de1-bf9d-2ec73346783e", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.0, "targetHighPrice": 8.25, "targetLowPrice": 3.5, "targetMeanPrice": 5.69, "targetMedianPrice": 5.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 11742000, "totalCashPerShare": 0.49, "quickRatio": 8.957, "currentRatio": 9.156, "returnOnAssets": -0.70081, "returnOnEquity": -1.55124, "freeCashflow": -5617750, "operatingCashflow": -9282000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-21"}]